LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

LLY

981.29

-2.24%↓

JNJ

239.53

-2.3%↓

ABBV

232.07

-1.66%↓

NVS

160.95

-2.49%↓

AZN

197.36

-2.11%↓

Home・Список акций・Vivani Medical

Vivani Medical

Открыт

1.15 -2.54

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1.13

Макс.

1.18

Ключевые показатели
By Trading Economics
Доход	614K -6.5M
Сотрудники	37

Дивиденды
By Dow Jones
Следующий отчет о доходах	30 мар. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-21M 83M
Предыдущая цена открытия	3.69
Предыдущая цена закрытия	1.15

Vivani Medical График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

4 мар. 2026 г., 23:39 UTC

Популярные акции

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 мар. 2026 г., 23:20 UTC

Отчет

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 мар. 2026 г., 21:43 UTC

Отчет

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 мар. 2026 г., 23:48 UTC

Обсуждения рынка

Nikkei May Rise After Recent Selloffs -- Market Talk

4 мар. 2026 г., 23:33 UTC

Обсуждения рынка

Главные новостные события

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 мар. 2026 г., 23:24 UTC

Обсуждения рынка

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 мар. 2026 г., 22:30 UTC

Отчет

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 мар. 2026 г., 22:30 UTC

Отчет

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 мар. 2026 г., 22:30 UTC

Отчет

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 мар. 2026 г., 22:13 UTC

Отчет

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 мар. 2026 г., 22:13 UTC

Отчет

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 мар. 2026 г., 22:13 UTC

Отчет

Vermilion Energy 4Q EPS C$2.86 >VET

4 мар. 2026 г., 22:04 UTC

Обсуждения рынка

RBA Slipping Behind The Curve On Rates -- Market Talk

4 мар. 2026 г., 21:53 UTC

Отчет

Lithium Americas 4Q Rev $66.8M >LAC

4 мар. 2026 г., 21:53 UTC

Отчет

Lithium Americas 4Q Loss/Shr 52c >LAC

4 мар. 2026 г., 21:52 UTC

Отчет

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 мар. 2026 г., 21:50 UTC

Отчет

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 мар. 2026 г., 21:50 UTC

Обсуждения рынка

Tech, Media & Telecom Roundup: Market Talk

4 мар. 2026 г., 21:48 UTC

Отчет

Webull 4Q Rev $165.2M >BULL

4 мар. 2026 г., 21:48 UTC

Отчет

Webull 4Q EPS 1c >BULL

4 мар. 2026 г., 21:45 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

4 мар. 2026 г., 21:45 UTC

Обсуждения рынка

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 мар. 2026 г., 21:40 UTC

Отчет

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 мар. 2026 г., 21:36 UTC

Главные новостные события

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 мар. 2026 г., 21:27 UTC

Отчет

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 мар. 2026 г., 21:17 UTC

Обсуждения рынка

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 мар. 2026 г., 21:16 UTC

Отчет

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 мар. 2026 г., 21:15 UTC

Отчет

Broadcom 1Q EPS $1.50 >AVGO

4 мар. 2026 г., 21:15 UTC

Отчет

Broadcom 1Q Net $7.35B >AVGO

4 мар. 2026 г., 21:15 UTC

Отчет

Broadcom 1Q Rev $19.31B >AVGO

Сравнение c конкурентами

Изменение цены

Vivani Medical Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

Покупка

Удержание

Продажа

Основано на мнении 0 аналитиков, присваивавших рейтинги акциям Vivani Medical – Данные за последние 3 месяца.

Финансовые показатели

Расходы на продажи и администрирование

Прибыль до уплаты налогов

Продажи

Операционная прибыль

О компании Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.